Skip to content

A prospective observational study on the incidence of polycystic ovary syndrome caused by acyl-CoA binding protein

A prospective observational study on the incidence of polycystic ovary syndrome caused by acyl-CoA binding protein

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082784
Enrollment
Unknown
Registered
2024-04-08
Start date
2024-04-08
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

Control Group:none

Sponsors

Women's Hospital School Of Medicine Zhejang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: PCOS group patients: patients treated in our hospital. The diagnosis complies with the 2003 Rotterdam criteria, specifically including: oligoovulation or anovulation: clinical manifestations of hyperandrogenism and/or hyperandrogenism: manifestations of =12 follicles with a diameter of 2 to 9 mm on one or both sides of the ovary and ( or) Polycystic ovarian changes with ovarian volume =10 mL; PCOS will be diagnosed if 2 of the above 3 criteria are met and other diseases are excluded. CON group: women who visited our hospital, had regular menstrual cycles and normal ovarian function.

Exclusion criteria

Exclusion criteria: Suffering from diabetes; suffering from other diseases that may cause hyperandrogenemia, such as congenital adrenal hyperplasia, Cushing's syndrome, etc.; acute or chronic infections or systemic inflammatory diseases; other diseases that may affect follicle development, such as hyperprolactinemia Patients with thyroid disease, thyroid disease, premature ovarian failure, etc. or those with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
acyl-CoA binding protein;

Countries

China

Contacts

Public ContactZhang Dan

Women's Hospital School Of Medicine Zhejang University

zhangdan@zju.edu.cn+86 137 3580 8888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026